Search - tctmd.com

Displaying 41 - 60 of 302

Sort: Relevancy | Date

News Industry News

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

October 20, 2015

$Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?$

Presentation TCT 2015

Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?

Presenter: Carlo Briguori, Roxana Mehran, Carey D. Kimmelstiel

October 15, 2015

Presentation TCT 2015

MATRIX Trial Recap: Interaction Between Access Site and Antithrombin Choice in ACS

Presenter: Carlo Briguori, Roxana Mehran

October 15, 2015

Presentation TCT 2015

The REG1 Anticoagulation System: Lessons From Factor IX Inhibitor Using RNA Aptamer Technology

Presenter: Carlo Briguori, Roxana Mehran

October 15, 2015

Presentation TCT 2015

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Presenter: Somjot S. Brar, Richard Solomon, Roxana Mehran

October 15, 2015

Presentation TCT 2015

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Presenter: Pascal Vranckx, Roxana Mehran

October 14, 2015

News Conference News TCT 2015

TCT Remembers Liliana Grinfeld, MD, PhD

October 14, 2015

News Conference News TCT 2015

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

October 14, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 4 Academia Perspectives

Presenter: Roxana Mehran, Laura Mauri

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 3 Industry Perspectives

Presenter: Roxana Mehran, Keith D. Dawkins

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 2 EMA Perspectives

Presenter: Roxana Mehran, Angeles Alonso Garcia

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 1 FDA Perspectives

Presenter: Roxana Mehran, John C Laschinger

October 13, 2015

Presentation TCT 2015

Is the Answer Pragmatic/Simple Trials? Are They Really So Simple?

Presenter: Roxana Mehran, Robert A. Harrington

October 13, 2015

Presentation TCT 2015

KEYNOTE LECTURE: Redefining Clinical Research and Patient Care: The New Era of Big Data, Precision Medicine, and Digital Health

Presenter: Roxana Mehran, Bram D. Zuckerman, Aaron V. Kaplan, Robert A. Harrington

October 13, 2015

Presentation TCT 2015

KEYNOTE LECTURE: An FDA Changing Vision for Medical Device Regulation Innovation, Speed-to-Market, Patient Safety, and Creative Clinical Research Pathways

Presenter: Roxana Mehran, Bram D. Zuckerman, Aaron V. Kaplan, Jeffrey Shuren

October 13, 2015

Presentation TCT 2015

Keynote Lecture 3: Single-Center vs Multicenter Trials Pros, Cons, and Integration Into Evidence

Presenter: Ajay J. Kirtane, Roxana Mehran, Sanjay Kaul

October 12, 2015

Presentation TCT 2015

HOT TOPIC 6: Importance of Evaluating Competing and Recurrent Events Within Clinical Trials Clinician/Trialist Perspective

Presenter: Ajay J. Kirtane, Roxana Mehran, Robert A. Harrington

October 12, 2015

Presentation TCT 2015

HOT TOPIC 6: Importance of Evaluating Competing and Recurrent Events Within Clinical Trials Statistical Perspective

Presenter: Ajay J. Kirtane, Roxana Mehran, Eugene H. Blackstone

October 12, 2015

Presentation TCT 2015

Keynote Lecture 2: The Case for (and the Arguments Against) Moving Quality-of-Life Assessment Front and Center in Clinical Trials

Presenter: Ajay J. Kirtane, Roxana Mehran, John A. Spertus

October 12, 2015

Presentation TCT 2015

Keynote Lecture 1: Advantages, Pitfalls, and Analysis Options for Composite Endpoints

Presenter: Ajay J. Kirtane, Roxana Mehran, Stuart J. Pocock

October 12, 2015

Advertisement

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?

MATRIX Trial Recap: Interaction Between Access Site and Antithrombin Choice in ACS

The REG1 Anticoagulation System: Lessons From Factor IX Inhibitor Using RNA Aptamer Technology

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

TCT Remembers Liliana Grinfeld, MD, PhD

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

Big Data: Opportunities and Challenges 4 Academia Perspectives

Big Data: Opportunities and Challenges 3 Industry Perspectives

Big Data: Opportunities and Challenges 2 EMA Perspectives

Big Data: Opportunities and Challenges 1 FDA Perspectives

Is the Answer Pragmatic/Simple Trials? Are They Really So Simple?

KEYNOTE LECTURE: Redefining Clinical Research and Patient Care: The New Era of Big Data, Precision Medicine, and Digital Health

KEYNOTE LECTURE: An FDA Changing Vision for Medical Device Regulation Innovation, Speed-to-Market, Patient Safety, and Creative Clinical Research Pathways

Keynote Lecture 3: Single-Center vs Multicenter Trials Pros, Cons, and Integration Into Evidence

HOT TOPIC 6: Importance of Evaluating Competing and Recurrent Events Within Clinical Trials Clinician/Trialist Perspective

HOT TOPIC 6: Importance of Evaluating Competing and Recurrent Events Within Clinical Trials Statistical Perspective

Keynote Lecture 2: The Case for (and the Arguments Against) Moving Quality-of-Life Assessment Front and Center in Clinical Trials

Keynote Lecture 1: Advantages, Pitfalls, and Analysis Options for Composite Endpoints

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content